Forget about Medibank, CMP is trading at P/E of 9

Just to highlight the key from latest announcement. NPAT of $2m in 2015.
Given share price at 0.11, that's about P/E ratio of 9. Not to mention its market cap is only about $20 millions with lucrative contract and being market leader in sleep diagnostic in nations, including emerging countries, such as CHina and south america.

The current trading volume is next to nothing with directors holding more than 60% of the shares.
One key question "are they scared to see price share drop to nothing?" Ans "NO, because CMP will be generating millions of profits, growing much fast than the rest of market "

2014: NPAT about $1million,
2015: NPAT about $2million, with 6% margin with ongoing relocation of manufacturing to lower cost nations and expansion into market
My guess for the year after that is
2016 NPAT about $4 million
2017 NPAT about $5 million

But, they are not important, because I expect CMP to have a market cap at least $100 millions in five year time.

Investors flock to buy Medibank IPO trading at 16-20 P/E ratio, When CMP is trading at 9 P/E with massive growth.
No wonder stock brokers earn so much profit, because a lot of investors do not think clearly but love listening to the media and advice, thinking "everyone is buying Medibank, I better get some myself"!

I mean that's cool. But, at moment, I am only interest to see CMP to grow at least 10 times in size.